Answers are grounded in this paper and cite their sources.
Risk assessment is a cross-disciplinary subject that is defined only by the problem to be solved and has no clear scientific domain boundaries.Procedures for health risk assessment are evolving continuously, and something better is always in need.Although epidemiological data have been playing important roles in health risk assessment, the need for innovation remains; therefore, it is desirable to make a concerted effort to explore their potential utility.In this special issue, a broad range of issues relevant to the use of epidemiological data for health risk assessment are addressed.Appropriate human data from epidemiological studies, if available, provide the most direct information for health risk.assessment because they avoid the need to extrapolate from animals to humans.The need to make epidemiological data more useful for risk assessment has been recognized in the past as underscored by a series of editorials and commentaries [1][2][3][4][5].Epidemiological studies can be made more useful for health risk assessment by improving study designs, and/or methods of data analysis.For instance, Woodruff et al. [6] suggests that human data can be made more useful for risk assessment if some early biomarkers can be identified.They reviewed what was known about the relationship between chemical exposure, early biological effects (upstream events), and later overt effects (down stream events) through case studies of chemical-induced ill effects, and concluded that certain classes of upstream events can serve as useful biomarkers for identifying hazard, and risk prediction.With respect to data analysis, epidemiological data have traditionally been used to estimate risk to humans due to exposure to an agent [7][8][9][10][11].Recently, epidemiological data have been used to characterize the lingering effects after cessation, or reduction of exposures by exploiting the dynamic nature of these data where each individual can be considered as an independent experiment with different exposure scenarios and follow up periods [12,13].The concept of effect lingering is closely related to that of cessation lag, the time required for risk to reduce to a certain level after cessation or reduction of exposure.The concept of cessation lag is useful for the analysis of economic benefits of an environmental regulation because the result is sensitive to the timing of the risk reductions and cannot be effectively addressed by the conventional dose-response procedures.Therefore, both risk estimation, and characterization of lingering and cessation effect are useful for environmental management, and regulatory decision making.
No takes yet. Share an insight, caveat, or question.
Chao W. Chen (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: